This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Zhou P, Yang X Lou, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273.ZhouPYangX LouWangXGet alA pneumonia outbreak associated with a new coronavirus of probable bat origin2020579779827027310.1038/s41586-020-2012-7709541832015507Search in Google Scholar
Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733.ZhuNZhangDWangWet alA Novel Coronavirus from Patients with Pneumonia in China, 20192020382872773310.1056/NEJMoa2001017709280331978945Search in Google Scholar
Mahase E. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ. 2020;368(February):m641.MahaseECoronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate2020368Februarym64110.1136/bmj.m64132071063Search in Google Scholar
CRC JHCRC. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU).CRC JHCRCSearch in Google Scholar
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Ann Oncol. 2020;(January):19-21.ConnorsJMLevyJHCOVID-19 and its implications for thrombosis and anticoagulation2020January192110.1182/blood.2020006000727382732339221Search in Google Scholar
Gupta A, Malviya A. Chloroquine and hydroxychloroquine for COVID-19: Time to close the chapter. Postgrad Med J. 2020:1-2.GuptaAMalviyaAChloroquine and hydroxychloroquine for COVID-19: Time to close the chapter20201210.1136/postgradmedj-2020-13858532788309Search in Google Scholar
Luo E, Zhang D, Luo H, et al. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China. Chinese Med (United Kingdom). 2020;15(1):1-13.LuoEZhangDLuoHet alTreatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei Province, China202015111310.1186/s13020-020-00317-x715689632308732Search in Google Scholar
Marietta M, Ageno W, Artoni A, et al. COVID-19 and haemostasis: A position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. 2020;18(3):167-169.MariettaMAgenoWArtoniAet alCOVID-19 and haemostasis: A position paper from Italian Society on Thrombosis and Haemostasis (SISET)2020183167169Search in Google Scholar
Pelaia C, Tinello C, Ventrella A, De Sarro G, Pelaia G. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications. Ther Adv Respir Dis. 2020;9(6):259-261.PelaiaCTinelloCVentrellaADe SarroGPelaiaGLung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications20209625926110.1177/1753466620933508729842532539627Search in Google Scholar
Saha A, Ahsan MM, Quader MTU, et al. Clinical characteristics and outcomes of COVID-19 infected diabetic patients admitted in ICUs of the southern region of Bangladesh. Diabetes Metab Syndr Clin Res Rev. 2021;15(1):229-235.SahaAAhsanMMQuaderMTUet alClinical characteristics and outcomes of COVID-19 infected diabetic patients admitted in ICUs of the southern region of Bangladesh202115122923510.1016/j.dsx.2020.12.037783724933445071Search in Google Scholar
Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215-220.LanJGeJYuJet alStructure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor2020581780721522010.1038/s41586-020-2180-532225176Search in Google Scholar
Caini S, Bellerba F, Corso F, et al. Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications. Eurosurveillance. 2020;25(23):1-5.CainiSBellerbaFCorsoFet alMeta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 220 and public health implications202025231510.2807/1560-7917.ES.2020.25.23.2000980740364132553061Search in Google Scholar
To KKW, Tsang OTY, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565-574.ToKKWTsangOTYLeungWSet alTemporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study202020556557410.1016/S1473-3099(20)30196-1Search in Google Scholar
Kontou PI, Braliou GG, Dimou NL, Nikolopoulos G, Bagos PG. Antibody tests in detecting SARS-CoV-2 infection: a meta-analysis. medRxiv. 2020.KontouPIBraliouGGDimouNLNikolopoulosGBagosPGAntibody tests in detecting SARS-CoV-2 infection: a meta-analysis202010.3390/diagnostics10050319727800232438677Search in Google Scholar
Amanat F, Stadlbauer D, Strohmeier S, et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. medRxiv. 2020;2.AmanatFStadlbauerDStrohmeierSet alA serological assay to detect SARS-CoV-2 seroconversion in humans2020210.1038/s41591-020-0913-5818362732398876Search in Google Scholar
Seow J, Graham C, Merrick B, et al. Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection 2. medRxiv. 2020;(165):1-13.SeowJGrahamCMerrickBet alLongitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection 2202016511310.1101/2020.07.09.20148429Search in Google Scholar
Bruni M, Cecatiello V, Diaz-Basabe A, et al. Persistence of anti-SARS-CoV-2 antibodies in non-hospitalized COVID-19 convalescent health care workers. medRxiv. 2020.BruniMCecatielloVDiaz-BasabeAet alPersistence of anti-SARS-CoV-2 antibodies in non-hospitalized COVID-19 convalescent health care workers202010.3390/jcm9103188760093633019628Search in Google Scholar